ClinicalTrials.gg

Breast Feeding clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,083 studies for Breast Feeding across more than 10 countries. 218 are recruiting or about to start. 762 of them are mainly about Breast Feeding (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its narrower condition Breast Milk Expression too: 1,146 studies, 231 open.

ClinicalTrials.gov finds 1,462 studies for Breast Feeding. How that becomes 1,080 here

This page counts the studies the registry files under Breast Feeding, and those it files under no condition that list Breast Feedingthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,462Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −63Filed under a narrower condition, counted on its own pageBreast Milk Expression 63
  3. −9List Breast Feeding as a condition, but the registry did not file them under itMost often written as “Breastfeeding Self-Efficacy” (3), “Maternal Breastfeeding in Newborns” (1), and “Maternal Nipple Pain Upon Breastfeeding” (1). The registry filed them under other conditions only, most often Depression, Postpartum (3) and Communication Disorders (1).
  4. −310Match it another way165 name it in the title, 18 in a keyword, and 127 by a synonym or other text the search reads.
  5. 1,080The count on this page48 of them list Breast Feeding in their own words; the registry filed them under no condition.

Status

Completed
680
Recruiting
127
Status unknown
94
Not yet recruiting
82
Active, not recruiting
37
Withdrawn
29

Phase

Phase 4
37
Phase 3
29
Phase 2
27
Phase 1
17
Early Phase 1
2

Where

Turkey
274
United States
251
Spain
35
France
34
Canada
33
Israel
21

Who develops what

Add Breast Feeding to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 1 program from 1 company, 1 with this as their studies’ main aim; 0 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 1 program — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Breast Feeding studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Hormonal contraceptives 6 · Antiemetics 4 · Reverse transcriptase inhibitors 3

Coming up

71studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 127 Breast Feeding studies recruiting now, 66 (52%) set no upper age limit and 59 (46%) stop at 75 or younger. 53 (42%) take children under 18. 79 (62%) are for women only and 1 (1%) for men only; 76 (60%) take healthy volunteers.

Recruiting studies that take each age, of 127
AgeWomenMen
1029 (23%)16 (13%)
18103 (81%)30 (24%)
30110 (87%)32 (25%)
40100 (79%)29 (23%)
5075 (59%)22 (17%)
6568 (54%)20 (16%)
7567 (53%)19 (15%)
8567 (53%)19 (15%)

Across all 1,083 studies, recruiting or not: 56% stop at 75 or younger and 56% at 65; 40% take children; 69% are for women only and 1% for men only; 68% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Breast Feeding studies take

Of 17 phase 4 interventional studies under Breast Feeding, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 414 mo7–30 · 17 studies——
Interventional, no phase12 mo6–23 · 512 studies—12 mo6–23 · 504 studies
Observational33 mo19–73 · 96 studies—31 mo19–54 · 86 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 1,083. Browse all 1,083 → or search them.